Given that problems of lack of affordable medicines are not limited to WTO member, the scope of the regulation should be extended to include also developing countries and least-developed countries.
Given that problems of lack of affordable medicines are not limited to WTO member, the scope of the regulation should be extended to include also developing countries and least-developed countries.